George Poste
Insider at Caris Life Sciences, Inc. (CAI) since June 2025
George Poste has filed 19 insider reports with the SEC since February 2021, as insider at Caris Life Sciences, Inc. (CAI) and director at Exelixis, Inc. (EXEL). In the last 12 months George Poste sold $2.74M of stock on the open market. The latest filing, on August 24, 2026, is a Form 144 notice: George Poste plans to sell 100,000 CAI shares (~$2.61M).
Planned sale (Form 144)
- George Poste plans to sell 100,000 CAI shares (~$2.61M), around Aug 24, 2026. Notice filed Aug 24, 2026.
A Form 144 is a notice of a proposed sale, not a trade. The sale itself shows up in a later Form 4.
- Filings
- 19
- Companies
- 2
- Bought on market
- None
- Sold on market
- $7.08M
Companies where George Poste is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Insidersince June 2025 | 17,729 | $21.00 | Aug 24, 2026 | ||||
| Director | 127,199 | $7.08M | $67.10 | May 29, 2026 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Aug 24, 2026~$2.61MCAIGeorge Poste plans to sell 100,000 shares (~$2.61M)Form 144Planned sale
- Aug 7, 2026~$643KCAIGeorge Poste plans to sell 30,000 shares (~$643K)Form 144Planned sale
- Aug 3, 2026~$325KCAIGeorge Poste plans to sell 20,000 shares (~$325K)Form 144Planned sale
- May 29, 2026CAIDirector Poste George was granted 1,600 shares, increasing direct ownership by 10% to 17,729 unitsForm 4Grant or award
- May 27, 2026EXELDirector Poste George was granted 8,367 shares, increasing direct ownership by 7% to 127,199 unitsForm 4Grant or award
- May 7, 2026-$2.74MEXELDirector Poste George sold $2,742,600 worth of shares (60,000 units at $45.71), decreasing direct ownership by 34% to 118,832 unitsForm 4Open-market sale
- Aug 11, 2025CAIDirector Poste George exercised 125,000 shares at a strike of $2.44 and covered exercise/tax liability with 139,517 shares, decreasing direct ownership by 6% to 220,237 unitsForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- Jun 17, 2025CAINew insider Poste George claimed ownership of 542,348 sharesForm 3New insider
- May 29, 2025EXELDirector Poste George was granted 9,812 shares, increasing direct ownership by 6% to 178,832 unitsForm 4Grant or award
- May 16, 2025-$949KEXELDirector Poste George exercised 20,634 shares at a strike of $19.77 and sold $948,958 worth of shares (20,634 units at $45.99)Form 4Exercise or conversion of a derivativeOpen-market sale
- Feb 14, 2025-$551KEXELDirector Poste George exercised 15,874 shares at a strike of $20.50 and sold $551,463 worth of shares (15,874 units at $34.74)Form 4Exercise or conversion of a derivativeOpen-market sale
- Nov 1, 2024-$1.02MEXELDirector Poste George sold $1,020,000 worth of shares (30,000 units at $34.00), decreasing direct ownership by 15% to 169,020 unitsForm 4Open-market sale
- Aug 8, 2024-$907KEXELDirector Poste George sold $906,865 worth of shares (33,725 units at $26.89), decreasing direct ownership by 14% to 199,020 unitsForm 4Open-market sale
- May 31, 2024EXELPoste George was granted 18,838 shares, increasing direct ownership by 9% to 232,745 unitsForm 4Grant or award
- May 21, 2024-$245KEXELPoste George exercised 11,686 shares at a strike of $19.57 and sold $244,939 worth of shares (11,686 units at $20.96)Form 4Exercise or conversion of a derivativeOpen-market sale
- Jun 1, 2023EXELSEC Form 4 filed by Poste GeorgeForm 4Grant or award
- Nov 29, 2022-$667KEXELSEC Form 4: Poste George exercised 40,000 shares at a strike of $6.30 and sold $667,200 worth of shares (40,000 units at $16.68)Form 4Exercise or conversion of a derivativeOpen-market sale
- May 26, 2022EXELSEC Form 4: Poste George was granted 19,575 shares, increasing direct ownership by 11% to 193,189 unitsForm 4Grant or award
- Feb 22, 2021EXELSEC Form 4: George Poste exercised 40,000 units of Common Stock at a strike of $3.38, increasing ownership by 25% to 197,992 unitsForm 4Exercise or conversion of a derivative
Compare George Poste with
- George Poste vs John Russel Denton1 shared
- George Poste vs Brian J Brille1 shared
- George Poste vs Peter M Castleman1 shared
- George Poste vs T Danny Phillips1 shared
- George Poste vs Lloyd Minor1 shared
- George Poste vs Joseph E Gilliam1 shared
Other insiders at the same companies
- John Russel DentonCAI
- Brian J BrilleCAI
- Peter M CastlemanCAI
- T Danny PhillipsCAI
- Lloyd MinorCAI
- Joseph E GilliamCAI
- David Paul FredricksonCAI
- Jeff L VacircaCAI
- Laura I JohansenCAI
- Jon HalbertCAI
- Mary C BeckerleEXEL
- Jack L WyszomierskiEXEL
- Sue Gail EckhardtEXEL
- Knowles Jonathan Kenneth CharlesCAI
- Stelios PapadopoulosEXEL
- Tomas J. HeymanEXEL
Questions about George Poste
- What is George Poste's role at Caris Life Sciences, Inc.?
- George Poste reports to the SEC as insider at Caris Life Sciences, Inc. (CAI), according to the latest filing on August 24, 2026. George Poste has also filed as director at Exelixis, Inc. (EXEL).
- How many shares does George Poste own?
- After the latest filing that states it, George Poste directly owned 17,729 shares of Caris Life Sciences, Inc. (CAI) and 127,199 shares of Exelixis, Inc. (EXEL). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has George Poste bought or sold stock recently?
- The most recent open-market sale was on May 7, 2026: sold 60,000 shares of Exelixis, Inc. (EXEL) for $2.74M at an average of $45.71.
- How do I get alerts when George Poste files?
- Follow George Poste on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale. George Poste filed 1 time in the last 90 days.
From SEC Forms 3, 4, 5 and 144 filed by George Poste (SEC CIK 0001180770). Totals count each trade once, skipping amendments whose original is on file, from Feb 25, 2021 on. View on SEC EDGAR